Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2251 AL 2265

Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential

Javaid N, Shah MA, Rasul A, Chauhdary Z, Saleem U, Khan H, Ahmed N, Uddin MS, Mathew B, Behl T, Blundell R.

Curr Pharm Des. 2021;27(34):3591-3601. doi: 10.2174/1381612826666201112144006.

Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease

Uddin MS, Hasana S, Ahmad J, Hossain MF, Rahman MM, Behl T, Rauf A, Ahmad A, Hafeez A, Perveen A, Ashraf GM.

Curr Pharm Des. 2021;27(3):402-414. doi: 10.2174/1381612826666201118092422.

c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations

Busquets O, Parcerisas A, Verdaguer E, Ettcheto M, Camins A, Beas-Zarate C, Castro-Torres RD, Auladell C.

J Alzheimers Dis. 2021;82(s1):S127-S139. doi: 10.3233/JAD-201053.

Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation

Liu Y, Cong L, Han C, Li B, Dai R.

Mini Rev Med Chem. 2021;21(8):969-990. doi: 10.2174/1389557520666201127104539.

Current Quest in Natural Bioactive Compounds for Alzheimer's Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence

Iqubal A, Rahman SO, Ahmed M, Bansal P, Haider MR, Iqubal MK, Najmi AK, Pottoo FH, Haque SE.

Curr Drug Targets. 2021;22(6):685-720. doi: 10.2174/1389450121999201209201004.

The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators

Pan L, Ma Y, Li Y, Wu H, Huang R, Cai Z, Wu X.

Mini Rev Med Chem. 2021;21(11):1288-1302. doi: 10.2174/1389557520999201209211610.

Rapid drug access and scientific rigour: a delicate balance

The Lancet Neurology.

Lancet Neurol. 2021 Jan;20(1):1. doi: 10.1016/S1474-4422(20)30452-X.

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

Serrano-Pozo A, Das S, Hyman BT.

Lancet Neurol. 2021 Jan;20(1):68-80. doi: 10.1016/S1474-4422(20)30412-9.

First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M(1) -receptor partial agonist for the treatment of dementias

Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Prins S, van der Doef TF, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.

Br J Clin Pharmacol. 2021 Jul;87(7):2945-2955. doi: 10.1111/bcp.14710. Epub 2021 Feb 5.

Potential Epigenetic Targets for Combating Alzheimer's Disease

Pandey D, Pal T, Sharma A, Flora S.

Mini Rev Med Chem. 2021;21(12):1527-1540. doi: 10.2174/1389557521999201228191427.

Therapeutic Properties of Several Chemical Compounds of Salvia officinalis L. in Alzheimer's Disease

Uță G, Manolescu DȘ, Avram S.

Mini Rev Med Chem. 2021;21(12):1421-1430. doi: 10.2174/1389557521999201230200209.

Recent Advances in Nanotechnology-Based Drug Delivery Approaches for Alzheimer disease

Kaur I, Kumar A, Behl T, Setia D.

Curr Drug Targets. 2021;22(12):1404-1423. doi: 10.2174/1389450122999210104205018.

Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment

Bagheri-Mohammadi S.

Cell Tissue Bank. 2021 Sep;22(3):339-353. doi: 10.1007/s10561-020-09896-3. Epub 2021 Jan 4.

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer's disease

Yu W, Jin H, Huang Y.

Clin Sci (Lond). 2021 Jan 15;135(1):109-126. doi: 10.1042/CS20200844.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias